Zealand Pharma A/S
ZLDPF
$54.00
$0.480.90%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -60.50M | -59.09M | -63.32M | 1.15B | -47.26M |
| Total Depreciation and Amortization | 1.54M | 719.50K | 1.13M | 944.80K | 705.30K |
| Total Amortization of Deferred Charges | -- | 3.18M | -- | -- | -- |
| Total Other Non-Cash Items | -1.23M | -189.20M | 18.46M | 157.12M | 1.41M |
| Change in Net Operating Assets | -42.99M | 81.85M | -25.78M | -14.23M | -25.53M |
| Cash from Operations | -103.18M | -162.54M | -69.52M | 1.30B | -70.67M |
| Capital Expenditure | -1.54M | -2.63M | -570.80K | -977.00K | -846.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.28M | -55.58M | -133.43M | -238.49M | 79.14M |
| Cash from Investing | -17.81M | -58.21M | -134.00M | -239.46M | 78.29M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.00M | -5.98M | -5.42M | -4.43M | -4.00M |
| Issuance of Common Stock | 1.00M | 16.62M | 1.90M | 27.09M | 3.00M |
| Repurchase of Common Stock | -- | -- | -74.76M | -332.41M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.23M | 1.66M | -12.26M | -47.12M | -141.10K |
| Foreign Exchange rate Adjustments | 10.44M | 1.47M | 16.63M | -25.47M | -423.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.78M | -217.61M | -199.15M | 983.85M | 7.05M |